Lawrence A. Hilsheimer
Lawrence A. Hilsheimer's purchase track record
How the stock did after each of Lawrence A. Hilsheimer's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/11/2026 | IBP | $98K | +14.5% | pending | — |
| 2/3/2026 | GEF | $1.63M | -5.8% | +25.6% | +11.8% |
| 11/20/2025 | GEF | $74K | +22.3% | +6.3% | +13.9% |
| 11/12/2025 | GEF | $2.20M | +26.5% | +10.1% | +8.7% |
| 7/8/2025 | GEF | $67K | -11.6% | +5.4% | +11.6% |
| 12/20/2024 | GEF | $261K | -7.9% | +5.9% | +0.6% |
| 3/5/2024 | GEF | $3.12M | +1.9% | -1.0% | +8.9% |
| 12/26/2023 | GEF | $149K | +1.1% | -7.7% | +14.5% |
| 3/13/2023 | GEF | $929K | +19.0% | +14.2% | +16.4% |
| 1/6/2023 | GEF | $5K | -6.5% | +2.8% | +12.9% |
| 12/21/2022 | GEF | $487K | -11.2% | +1.4% | +12.6% |
| 9/7/2022 | GEF | $520 | +4.3% | -4.3% | +0.3% |
| 3/1/2022 | ROOT | $50K | -20.1% | -59.5% | -7.4% |
| 2/28/2022 | IBP | $50K | +0.0% | -2.1% | -7.8% |
| 1/7/2022 | GEF | $88K | +2.4% | +2.7% | -16.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Wells Fargo cuts Root price target to $47. Wells Fargo lowered its price target for Root to $47 while maintaining an Equal-Weight rating. This adjustment occurs as the stock trades near its 52-week low, with the new target sitting below the current average analyst estimate of $57. The move reflects a more cautious outlook for the insurer amidst broader industry developments.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
IBP Shares Fall as RBC Cuts Target and Melius Initiates Hold. Installed Building Products shares dropped alongside other industrial peers, partly due to RBC Capital lowering its price target to $208 and Melius Research initiating coverage with a Hold rating. While the stock is trading near its 52-week low, the average analyst target remains significantly higher at $239.92. The company also released its 2026 ESG report, but the recent focus has been on the mixed analyst outlook.
Transaction History
| GEF | ▼ Sell | Open Market | 21,500 | $1.9M | 8/7/2026 | View on chart |
| GEF | ▼ Sell | Open Market | 20,254 | $1.8M | 8/6/2026 | View on chart |
| ROOT | ▲ Buy | Grant | 2,864 | $0 | 6/3/2026 | View on chart |
| IBP | ▲ Buy | Grant | 855 | $0 | 5/19/2026 | View on chart |
| IBP | ▲ Buy | Open Market | 475 | $98K | 5/11/2026 | View on chart |
| IBP | ▼ Sell | Gift | 30 | $0 | 3/9/2026 | View on chart |
| GEF | ▲ Buy | Open Market | 6,475 | $591K | 2/4/2026 | View on chart |
| GEF | ▲ Buy | Open Market | 230 | $21K | 2/4/2026 | View on chart |
| GEF | ▼ Sell | Open Market | 14,465 | $1.0M | 2/3/2026 | View on chart |
| GEF | ▲ Buy | Open Market | 5,000 | $441K | 2/3/2026 | View on chart |
| GEF | ▼ Sell | Open Market | 8,313 | $596K | 2/3/2026 | View on chart |
| GEF | ▲ Buy | Open Market | 6,617 | $575K | 2/3/2026 | View on chart |
| GEF | ▲ Buy | Option Exercise | 11,675 | $0 | 1/14/2026 | View on chart |
| GEF | ▼ Sell | Tax Withholding | 3,362 | $0 | 1/14/2026 | View on chart |
| GEF | ▲ Buy | Grant | 36,921 | $0 | 1/14/2026 | View on chart |
| GEF | ▼ Sell | Tax Withholding | 15,629 | $0 | 1/14/2026 | View on chart |
| GEF | ▼ Sell | Gift | 1,031 | $0 | 12/19/2025 | View on chart |
| GEF | ▼ Sell | Gift | 146 | $0 | 12/19/2025 | View on chart |
| GEF | ▼ Sell | Gift | 146 | $0 | 12/19/2025 | View on chart |
| GEF | ▼ Sell | Gift | 146 | $0 | 12/19/2025 | View on chart |
| GEF | ▼ Sell | Gift | 74 | $0 | 12/19/2025 | View on chart |
| GEF | ▼ Sell | Gift | 74 | $0 | 12/19/2025 | View on chart |
| GEF | ▼ Sell | Gift | 31 | $0 | 12/3/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 1,125 | $74K | 11/20/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 1,000 | $66K | 11/19/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 1,000 | $65K | 11/18/2025 | View on chart |
| GEF | ▼ Sell | Open Market | 4,500 | $273K | 11/17/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 1,000 | $66K | 11/17/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 1,589 | $107K | 11/13/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 6,753 | $460K | 11/13/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 2,796 | $180K | 11/12/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 1,680 | $109K | 11/12/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 12,754 | $846K | 11/12/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 4,521 | $302K | 11/12/2025 | View on chart |
| GEF | ▼ Sell | Open Market | 33,851 | $2.0M | 11/11/2025 | View on chart |
| GEF | ▼ Sell | Open Market | 1,000 | $69K | 7/8/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 925 | $67K | 7/8/2025 | View on chart |
| ROOT | ▲ Buy | Grant | 1,119 | $0 | 6/4/2025 | View on chart |
| IBP | ▲ Buy | Grant | 775 | $0 | 5/20/2025 | View on chart |
| ROOT | ▲ Buy | Option Exercise | 258 | $2K | 4/4/2025 | View on chart |
| ROOT | ▼ Sell | Tax Withholding | 22 | $2K | 4/4/2025 | View on chart |
| ROOT | ▲ Buy | Option Exercise | 258 | $6K | 4/4/2025 | View on chart |
| ROOT | ▼ Sell | Tax Withholding | 51 | $6K | 4/4/2025 | View on chart |
| GEF | ▲ Buy | Option Exercise | 10,941 | $0 | 1/16/2025 | View on chart |
| GEF | ▼ Sell | Tax Withholding | 4,689 | $0 | 1/16/2025 | View on chart |
| GEF | ▲ Buy | Grant | 30,713 | $0 | 1/16/2025 | View on chart |
| GEF | ▼ Sell | Tax Withholding | 10,838 | $0 | 1/16/2025 | View on chart |
| GEF | ▲ Buy | Open Market | 1,075 | $74K | 12/26/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 1,100 | $75K | 12/24/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 1,100 | $74K | 12/23/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 550 | $37K | 12/20/2024 | View on chart |
| GEF | ▼ Sell | Gift | 85 | $0 | 12/20/2024 | View on chart |
| GEF | ▼ Sell | Gift | 170 | $0 | 12/20/2024 | View on chart |
| GEF | ▼ Sell | Gift | 170 | $0 | 12/20/2024 | View on chart |
| GEF | ▼ Sell | Gift | 3,850 | $0 | 12/20/2024 | View on chart |
| GEF | ▼ Sell | Gift | 85 | $0 | 12/20/2024 | View on chart |
| ROOT | ▲ Buy | Grant | 2,305 | $0 | 6/5/2024 | View on chart |
| IBP | ▲ Buy | Grant | 150 | $32K | 5/31/2024 | View on chart |
| IBP | ▼ Sell | Gift | 50 | $0 | 5/31/2024 | View on chart |
| IBP | ▲ Buy | Grant | 598 | $0 | 5/23/2024 | View on chart |
| GEF | ▼ Sell | Open Market | 2,700 | $174K | 3/12/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 2,525 | $170K | 3/12/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 5,641 | $383K | 3/11/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 8,559 | $577K | 3/11/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 3,300 | $220K | 3/8/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 543 | $36K | 3/8/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 3,300 | $215K | 3/7/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 4,063 | $264K | 3/7/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 3,000 | $193K | 3/6/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 3,898 | $250K | 3/6/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 4,602 | $298K | 3/6/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 8,000 | $516K | 3/5/2024 | View on chart |
| GEF | ▼ Sell | Open Market | 9,978 | $628K | 3/5/2024 | View on chart |
| GEF | ▼ Sell | Open Market | 100 | $6K | 3/5/2024 | View on chart |
| GEF | ▼ Sell | Open Market | 8,134 | $516K | 3/5/2024 | View on chart |
| GEF | ▼ Sell | Open Market | 28,919 | $1.8M | 3/5/2024 | View on chart |
| GEF | ▲ Buy | Option Exercise | 13,504 | $0 | 1/16/2024 | View on chart |
| GEF | ▼ Sell | Tax Withholding | 5,787 | $0 | 1/16/2024 | View on chart |
| GEF | ▲ Buy | Grant | 44,345 | $0 | 1/16/2024 | View on chart |
| GEF | ▼ Sell | Tax Withholding | 16,746 | $0 | 1/16/2024 | View on chart |
| GEF | ▲ Buy | Open Market | 1,510 | $102K | 12/27/2023 | View on chart |
| GEF | ▲ Buy | Open Market | 700 | $47K | 12/26/2023 | View on chart |
| GEF | ▼ Sell | Gift | 152 | $0 | 12/26/2023 | View on chart |
| GEF | ▼ Sell | Gift | 76 | $0 | 12/26/2023 | View on chart |
| GEF | ▼ Sell | Gift | 76 | $0 | 12/26/2023 | View on chart |
| GEF | ▼ Sell | Gift | 152 | $0 | 12/22/2023 | View on chart |
| GEF | ▼ Sell | Gift | 1,855 | $0 | 12/22/2023 | View on chart |
| ROOT | ▲ Buy | Grant | 7,792 | $0 | 8/16/2023 | View on chart |
| GEF | ▲ Buy | Open Market | 2,968 | $0 | 7/5/2023 | View on chart |
| GEF | ▼ Sell | Open Market | 2,968 | $206K | 7/3/2023 | View on chart |
| ROOT | ▲ Buy | Grant | 5,378 | $30K | 6/30/2023 | View on chart |
| IBP | ▲ Buy | Grant | 934 | $0 | 5/25/2023 | View on chart |
| ROOT | ▲ Buy | Grant | 6,150 | $30K | 3/31/2023 | View on chart |
| GEF | ▲ Buy | Open Market | 3,600 | $250K | 3/17/2023 | View on chart |
| GEF | ▲ Buy | Open Market | 3,500 | $244K | 3/16/2023 | View on chart |
| GEF | ▲ Buy | Open Market | 3,000 | $208K | 3/15/2023 | View on chart |
| GEF | ▼ Sell | Open Market | 14,596 | $885K | 3/14/2023 | View on chart |
| GEF | ▲ Buy | Open Market | 2,500 | $176K | 3/14/2023 | View on chart |
| GEF | ▼ Sell | Open Market | 833 | $51K | 3/13/2023 | View on chart |
| GEF | ▲ Buy | Open Market | 728 | $51K | 3/13/2023 | View on chart |
| GEF | ▲ Buy | Option Exercise | 14,850 | $0 | 1/17/2023 | View on chart |
| GEF | ▼ Sell | Tax Withholding | 6,364 | $0 | 1/17/2023 | View on chart |
| GEF | ▲ Buy | Grant | 47,088 | $0 | 1/17/2023 | View on chart |
| GEF | ▼ Sell | Tax Withholding | 18,109 | $0 | 1/17/2023 | View on chart |
| GEF | ▼ Sell | Gift | 75 | $0 | 1/6/2023 | View on chart |
| GEF | ▲ Buy | Open Market | 62 | $5K | 1/6/2023 | View on chart |
| ROOT | ▲ Buy | Grant | 4,566 | $30K | 12/30/2022 | View on chart |
| GEF | ▲ Buy | Open Market | 4,050 | $320K | 12/27/2022 | View on chart |
| GEF | ▼ Sell | Open Market | 4,750 | $318K | 12/23/2022 | View on chart |
| GEF | ▲ Buy | Open Market | 2,180 | $167K | 12/21/2022 | View on chart |
| GEF | ▼ Sell | Gift | 73 | $0 | 12/19/2022 | View on chart |
| GEF | ▼ Sell | Gift | 151 | $0 | 12/19/2022 | View on chart |
| GEF | ▼ Sell | Gift | 151 | $0 | 12/19/2022 | View on chart |
| GEF | ▼ Sell | Gift | 151 | $0 | 12/19/2022 | View on chart |
| GEF | ▼ Sell | Gift | 1,895 | $0 | 12/19/2022 | View on chart |
| ROOT | ▲ Buy | Grant | 2,297 | $30K | 9/30/2022 | View on chart |
| GEF | ▲ Buy | Open Market | 8 | $520 | 9/7/2022 | View on chart |
| GEF | ▼ Sell | Gift | 8 | $0 | 9/7/2022 | View on chart |
| ROOT | ▲ Buy | Grant | 22,941 | $30K | 6/30/2022 | View on chart |
| ROOT | ▲ Buy | Grant | 115,207 | $0 | 6/7/2022 | View on chart |
| IBP | ▲ Buy | Grant | 1,067 | $0 | 5/26/2022 | View on chart |
| ROOT | ▲ Buy | Grant | 17,552 | $30K | 3/31/2022 | View on chart |
| ROOT | ▲ Buy | Open Market | 28,735 | $50K | 3/1/2022 | View on chart |
| IBP | ▲ Buy | Open Market | 513 | $50K | 2/28/2022 | View on chart |
| GEF | ▲ Buy | Open Market | 745 | $45K | 1/10/2022 | View on chart |
| GEF | ▲ Buy | Open Market | 200 | $12K | 1/7/2022 | View on chart |
| GEF | ▲ Buy | Open Market | 136 | $8K | 1/7/2022 | View on chart |
| GEF | ▲ Buy | Open Market | 369 | $22K | 1/7/2022 | View on chart |
| GEF | ▼ Sell | Gift | 85 | $0 | 12/30/2021 | View on chart |
| GEF | ▼ Sell | Gift | 85 | $0 | 12/30/2021 | View on chart |
| GEF | ▼ Sell | Gift | 85 | $0 | 12/30/2021 | View on chart |
| GEF | ▼ Sell | Gift | 1,204 | $0 | 12/30/2021 | View on chart |
| GEF | ▲ Buy | Grant | 6,110 | $0 | 12/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Raymond James Upgrades Greif to Outperform with $90 Target
Raymond James upgraded Greif to Outperform and set a price target of $90. This follows Truist Securities maintaining a Hold rating while lowering its target to $94. Additionally, the company's emissions reduction targets were validated by the Science Based Targets initiative. These developments provide a mix of analyst perspectives and sustainability milestones for the stock.
Raymond James Upgrades Greif to Outperform with $90 Target. Raymond James upgraded Greif to Outperform and set a price target of $90. This follows Truist Securities maintaining a Hold rating while lowering its target to $94. Additionally, the company's emissions reduction targets were validated by the Science Based Targets initiative. These developments provide a mix of analyst perspectives and sustainability milestones for the stock.